Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novella Innovative Technology, Ltd. is an Israeli biotechnology company pioneering the development of fruit- and vegetable-derived cell complexes for the nutraceutical, functional food, and wellness industries. Utilizing its proprietary AuraCell™ precision-cultivation platform, the company grows high-potency, whole-cell botanical ingredients in controlled indoor environments without cultivating whole plants. This innovative approach, termed "Precision Botanicals," bypasses traditional agricultural constraints, slashing resource use (water, land, and labor) by up to 99% while ensuring year-round supply consistency, purity, and zero waste. Novella's first commercial product, Novella Strawberry (Strawberry∞), is a patent-pending whole-cell bioactive ingredient that preserves the natural synergy of the fruit's compounds, delivering antioxidant benefits up to 100 times stronger than conventional extracts. The company is actively scaling its manufacturing through strategic CDMO partnerships to support a commercial rollout in the North American market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novella.